Latest Breaking News On - Bjorn redfors - Page 1 : comparemela.com

New risk analysis strategy benefits chest pain patients compared to the usual testing approach

A study comparing two approaches for diagnosing heart disease found that a risk analysis strategy is superior to the usual approach of immediately performing functional tests or catheterization for low- to intermediate-risk patients with new-onset chest pain.

United statesColin berryJohnp greenwoodMichelled kelseyGianluca pontoneEmily hendersonRobertw yehManeshr patelChristopherm kramerMichaelg nannaVictor marinescuJamese udelsonJonathon leipsicSarah mullenWhitney hueyKevinj anstrom

Personalized evaluation for chest pain effective, may eliminate unnecessary testing

Personalized evaluation for chest pain effective, may eliminate unnecessary testing
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United statesNorth carolinaDuke universityColin berryGianluca pontoneRobertw yehManeshr patelShea hoganChristopherm kramerVictor marinescuMichael nannaJamese udelsonJonathon leipsicSarah mullenRobert byrneWhitney huey

Chest Pain Patients Benefit from Precision Diagnostic Testing Approach

A study comparing two approaches for diagnosing heart disease found that a risk analysis strategy is superior to the usual approach of immediately performing fu

United statesColin berryJohnp greenwoodGianluca pontoneMichelled kelseyRobertw yehManeshr patelChristopherm kramerMichaelg nannaVictor marinescuJamese udelsonJonathon leipsicSarah mullenKevinj anstromWhitney hueyCampbell rogers

FDA Approval and First Implant of Orsiro Mission Drug-Eluting Stent System in the U S

FDA Approval and First Implant of Orsiro Mission Drug-Eluting Stent System in the U S
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesMegha prasadKazim naqviYousif ahmadMaheshv madhavanDavid kandzariBahira shahimBjorn redforsDavid hayesJamesp howardOrsiro missionEvidence froma comprehensive network metaInterventional cardiology of the piedmont heart institutePiedmont heart instituteDrug administrationGroup of companies

Statin use associated with increased survival in severe COVID-19

E-Mail NEW YORK, NY (Feb. 26, 2021) People who took statins to lower cholesterol were approximately 50% less likely to die if hospitalized for COVID-19, a study by physicians at Columbia University Vagelos College of Physicians and Surgeons and NewYork-Presbyterian has found. Our study is one of the larger studies confirming this hypothesis and the data lay the groundwork for future randomized clinical trials that are needed to confirm the benefit of statins in COVID-19, says Aakriti Gupta, MD, a cardiologist at NewYork-Presbyterian/Columbia University Irving Medical Center and one of the co-lead authors of the study. If their beneficial effect bears out in randomized clinical trials, statins could potentially prove to be a low-cost and effective therapeutic strategy for COVID-19, adds co-lead author Mahesh V. Madhavan, MD, also a cardiologist at NewYork-Presbyterian/Columbia University Irving Medical Center.

New yorkUnited statesJonathan plattTimothyj poteruchaShayann nouriAakriti guptaJessicaa hennesseyAjayj kirtaneBehnood bikdeliChristina eckhardtSahila parikhDaniel brodieMatthewj cummingsErsiliam defilippisJianhua liDaniel burkhoff